Present invention represents process for the preparation of HMG-CoA reductsase inhibitors, in particular rosuvastatin calcium introducing L-malic acid as the source of chirality for the side chain
-
Page/Page column 31-32
(2010/11/25)
More Articles about upstream products of 925421-81-4